Production method of cough-relieving drug for espiratory systems of old people

Abstract

The present invention discloses a production method of an cough-relieving drug for respiratory systems of old people. A technical scheme comprises the following main points: the production method comprises the following steps: S1, preparing materials: weighing the following raw materials in parts by weight: 5-10 parts of loquat leaves, 2-8 parts of ginkgo seeds, 1-3 parts of herba ephedrae, 1-5 parts of rhizoma pinelliae, 3-8 parts of semen brassicae, 0.5-2 part of inula flowers, 2-4 parts of gecko, 1-5 parts of radix stemonae, 0.3-0.5 part of honey-fried cortex mori radicis, 1-10 parts of bulbus fritillariae cirrhosae, 4-7 parts of blend powder and 1-2 parts of refined honey; S2, conducting pretreatment: respectively putting all the raw materials except the blend powder and the refined honey in the step S1 into a glass container, sequentially adding 5 kg of warm water, soaking the materials for 1-5 h, and taking out the soaked materials for draining for a later use; and S3, conductingdrying: separately putting the raw materials cleaned in the step S2 into a dryer, adjusting a temperature to 50-90 DEG C, and conducting drying for 5-10 h at a low temperature. After being taken, thecough-relieving drug for the respiratory systems of the old people has effects of relieving cough and asthma.

Description

technical field [0001] The invention belongs to the field of antiasthmatic drugs, in particular to a method for producing an antiasthmatic drug for the elderly respiratory system. Background technique [0002] Asthma, also known as bronchial asthma, is a disease in which a variety of cells (such as eosinophils, mast cells, T lymphocytes, neutrophils, airway epithelial cells, etc.) and cellular components are involved in chronic airway inflammation. A common and frequently-occurring disease in humans. The pathogenesis of asthma is not fully understood, but it is generally believed to include allergy, chronic airway inflammation, airway hyperresponsiveness, dysregulation of airway nerves, genetic mechanisms, respiratory viral infections, neural signal transduction mechanisms, and airway remodeling. and their interactions. Among them, genetic factors can be reflected in many patients. For example, in the vast majority of patients' relatives (blood relationship, nearly three g...

AI Technical Summary

Problems solved by technology

[0004] The above-mentioned patent has the characteristics of simple dosage form, simple and convenient treatment, and convenient taking, etc., but it also has defects, such as: the production process is too simplistic, the processing method of each ingredient is not specified in detail, and the pills made by it are prone to laziness, which is not easy. Suitable for middle-aged and elderly people

Images